|
1
|
Lim MS and Enjeti AK: Safety of
anticoagulation in the treatment of venous thromboembolism in
patients with haematological malignancies and thrombocytopenia:
Report of 5 cases and literature review. Crit Rev Oncol Hematol.
105:92–99. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagler M, Kremer Hovinga JA, Alberio L,
Peter-Salonen K, von Tengg-Kobligk H, Lottaz D, Neerman-Arbez M and
Lämmle B: Thromboembolism in patients with congenital
afibrinogenaemia. Long-term observational data and systematic
review. Thromb Haemost. 116:722–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shlebak A: Antiphospholipid syndrome
presenting as cerebral venous sinus thrombosis: A case series and a
review. J Clin Pathol. 69:337–343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Samoš M, Bolek T, Ivanková J, Stančiaková
L, Kovář F, Galajda P, Kubisz P, Staško J and Mokáň M: Heparin
induced thrombocytopenia presenting with deep venous thrombosis and
pulmonary embolism successfully treated with rivaroxaban: Clinical
case report and review of current experiences. J Cardiovasc
Pharmacol. 68:391–394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McKeage K and Keating GM: Parnaparin: A
review of its use in the management of venous thromboembolism,
chronic venous disease and other vascular disorders. Drugs.
68:105–122. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pellegrini VD Jr: Prophylaxis against
venous thromboembolism after total hip and knee arthroplasty: A
critical analysis review. JBJS Rev. 3:01874474-201509000-00005.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Devlin R, Bonanno L and Badeaux J: The
incidence of thromboembolism formation following the use of
recombinant factor VIIa in patients suffering from blunt force
trauma compared with penetrating trauma: A systematic review. JBI
Database System Rev Implement Rep. 14:116–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barco S, Atema JJ, Coppens M, Serlie MJ
and Middeldorp S: Anticoagulants for the prevention and treatment
of catheter-related thrombosis in adults and children on parenteral
nutrition: A systematic review and critical appraisal. Blood.
15:369–377. 2017.
|
|
9
|
Piazza G, Mani V, Goldhaber SZ, Grosso MA,
Mercuri M, Lanz HJ, Schussler S, Hsu C, Chinigo A, Ritchie B, et
al: Magnetic resonance venography to assess thrombus resolution
with edoxaban monotherapy versus parenteral
anticoagulation/warfarin for symptomatic deep vein thrombosis: A
multicenter feasibility study. Vasc Med. 21:361–368. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maehama T, Okura H, Imai K, Saito K,
Yamada R, Koyama T, Hayashida A, Neishi Y, Kawamoto T and Yoshida
K: Systemic inflammation and left atrial thrombus in patients with
non-rheumatic atrial fibrillation. J Cardiol. 56:118–124. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nishimura S: Pathogenesis of chronic
inflammation revealed by in vivo imaging: Thrombus formation and
platelet function. Rinsho Ketsueki. 51:620–624. 2010.(In Japanese).
PubMed/NCBI
|
|
12
|
Mo XR, Luo XJ, Li CP, Pan XF and Zhou LL:
Effect of mannitol injection by intravenous catheter on ear vein
endothelial cell apoptosis and venous thrombus in rabbits. Eur Rev
Med Pharmacol Sci. 19:491–497. 2015.PubMed/NCBI
|
|
13
|
Shirai Y, Noguchi T, Kita S, Nakamura A,
Tanimoto H, Ishigaki N, Aoyama K and Yoshida T: A study of
usefulness for portal vein thrombus with edoxaban. Nihon Shokakibyo
Gakkai Zasshi. 113:439–440. 2016.(In Japanese). PubMed/NCBI
|
|
14
|
Fei D, Meng X, Zhao M, Kang K, Tan G, Pan
S, Luo Y, Liu W, Nan C, Jiang H, et al: Enhanced induction of heme
oxygenase-1 suppresses thrombus formation and affects the protein C
system in sepsis. Transl Res. 159:99–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lozano M, Escolar G, Schwarz HP, Hernández
R, Bozzo J and Ordinas A: Activated protein C inhibits thrombus
formation in a system with flowing blood. Br J Haematol.
95:179–183. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hadas K, Randriamboavonjy V, Elgheznawy A,
Mann A and Fleming I: Methylglyoxal induces platelet
hyperaggregation and reduces thrombus stability by activating PKC
and inhibiting PI3K/Akt pathway. PLoS One. 8:e744012013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi W, Li Q, Shen J, Ren L, Liu X, Wang Q,
He S, Wu Q, Hu H, Mao X and Zhu L: Modulation of platelet
activation and thrombus formation using a pan-PI3K inhibitor
S14161. PLoS One. 9:e1023942014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Srivastava AK, Kalita J, Haris M, Gupta RK
and Misra UK: Radiological and histological changes following
cerebral venous sinus thrombosis in a rat model. Neurosci Res.
65:343–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Naganuma Y, Ichii O, Otsuka S, Hashimoto Y
and Kon Y: Analysis of TdT-mediated dUTP nick end labeling
(TUNEL)-positive cells associated with cardiac myogenesis in mouse
embryo. J Vet Med Sci. 75:283–290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
González-Manchón C, Larrucea S, Pastor AL,
Butta N, Arias-Salgado EG, Ayuso MS and Parrilla R: Compound
heterozygosity of the GPIbalpha gene associated with
Bernard-Soulier syndrome. Thromb Haemost. 86:1385–1391. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hawbaker S: Venous thromboembolism in the
cancer population: Pathology, risk, and prevention. J Adv Pract
Oncol. 3:23–33. 2012.PubMed/NCBI
|
|
23
|
Vitale C, D'Amato M, Calabro P, Stanziola
AA, Mormile M and Molino A: Venous thromboembolism and lung cancer:
A review. Multidiscip Respir Med. 10:282015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ungprasert P, Tanratana P and Srivali N:
Autoimmune hemolytic anemia and venous thromboembolism: A
systematic review and meta-analysis. Thromb Res. 136:1013–1017.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fernandez MM, Hogue S, Preblick R and
Kwong WJ: Review of the cost of venous thromboembolism. Clinicoecon
Outcomes Res. 7:451–462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Santin BJ, Lohr JM, Panke TW, Neville PM,
Felinski MM, Kuhn BA, Recht MH and Muck PE: Venous duplex and
pathologic differences in thrombus characteristics between de novo
deep vein thrombi and endovenous heat-induced thrombi. J Vasc Surg
Venous Lymphat Disord. 3:184–189. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Corral J, Huntington JA, González-Conejero
R, Mushunje A, Navarro M, Marco P, Vicente V and Carrell RW:
Mutations in the shutter region of antithrombin result in formation
of disulfide-linked dimers and severe venous thrombosis. J Thromb
Haemost. 2:931–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vayá A, Gómez I, Mira Y, Ferrando F and
Corella D: Homocysteine levels in patients with deep vein
thrombosis lacking thrombophilic defects. Thromb Haemost.
99:1132–1134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dittmeier M, Wassmuth K, Schuhmann MK,
Kraft P, Kleinschnitz C and Fluri F: Dabigatran etexilate reduces
thrombin-induced inflammation and thrombus formation in
experimental ischemic stroke. Curr Neurovasc Res. 13:199–206. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pulimamidi VK, Murugesan V, Rajappa M,
Satheesh S and Harichandrakumar KT: Increased levels of markers of
oxidative stress and inflammation in patients with rheumatic mitral
stenosis predispose to left atrial thrombus formation. J Clin Diagn
Res. 7:2445–2448. 2013.PubMed/NCBI
|
|
31
|
Empana JP, Boulanger CM, Tafflet M, Renard
JM, Leroyer AS, Varenne O, Prugger C, Silvain J, Tedgui A, Cariou
A, et al: Microparticles and sudden cardiac death due to coronary
occlusion. The TIDE (Thrombus and Inflammation in sudden DEath)
study. Eur Heart J Acute Cardiovasc Care. 4:28–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sadowski M, Zabczyk M and Undas A:
Coronary thrombus composition: Links with inflammation, platelet
and endothelial markers. Atherosclerosis. 237:555–561. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li N, Guo W, Shi J, Xue J, Hu H, Xie D, Wu
M and Cheng S: Expression of the chemokine receptor CXCR4 in human
hepatocellular carcinoma and its role in portal vein tumor
thrombus. J Exp Clin Cancer Res. 29:1562010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yadava K, Sichelstiel A, Luescher IF,
Nicod LP, Harris NL and Marsland BJ: TSLP promotes
influenza-specific CD8+ T-cell responses by augmenting local
inflammatory dendritic cell function. Mucosal Immunol. 6:83–92.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Janda J, Plattet P, Torsteinsdottir S,
Jonsdottir S, Zurbriggen A and Marti E: Generation of equine
TSLP-specific antibodies and their use for detection of TSLP
produced by equine keratinocytes and leukocytes. Vet Immunol
Immunopathol. 147:180–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tate CM, Blosser W, Wyss L, Evans G, Xue
Q, Pan Y and Stancato L: LY2228820 dimesylate, a selective
inhibitor of p38 mitogen-activated protein kinase, reduces
angiogenic endothelial cord formation in vitro and in vivo. J Biol
Chem. 288:6743–6753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Diaz JA, Wrobleski SK, Pechota AR, Hawley
AE, Roelofs KJ, Doornbos NK, Gabriel JE, Reynolds G, Lester P,
Londy F, et al: P-selectin inhibition therapeutically promotes
thrombus resolution and prevents vein wall fibrosis better than
enoxaparin and an inhibitor to von Willebrand factor. J Vasc Surg
Venous Lymphat Disord. 2:1142014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rossaint J, Vestweber D and Zarbock A:
GDF-15 prevents platelet integrin activation and thrombus
formation. J Thromb Haemost. 11:335–344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guidetti GF, Canobbio I and Torti M:
PI3K/Akt in platelet integrin signaling and implications in
thrombosis. Adv Biol Regul. 59:36–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Su W, Chen Y, Wang C, Ding X, Rwibasira G
and Kong Y: Human cathelicidin LL-37 inhibits platelet aggregation
and thrombosis via Src/PI3K/Akt signaling. Biochem Biophys Res
Commun. 473:283–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
McFadyen J and Peter K: Forget about
thrombosis: Platelets and Alzheimer's disease, yet another sticky
situation. Sci Signal. 9:fs92016. View Article : Google Scholar : PubMed/NCBI
|
